Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial von Topol, Eric J, Mark, Daniel B, Lincoff, A Michael, Cohen, Eric, Burton, Jeffrey, Kleiman, Neal, Talley, David, Sapp, Shelly, Booth, Joan, Cabot, Catherine F, Anderson, Keaven M, Califf, Robert M

Volltext

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade von Topol, Eric J

Volltext

Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary Stenting von Steinhubl, Steven R, Tan, Walter A, Foody, JoAnne M, Topol, Eric J, for the EPISTENT Investigators

Volltext

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) dia... von MARSO, S. P, LINCOFF, A. M, ELLIS, S. G, BHATT, D. L, TANGUAY, J.-F, KLEIMAN, N. S, HAMMOUD, T, BOOTH, J. E, SAPP, S. K, TOPOL, E. J

Volltext

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events : Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Sten... von STEINHUBL, Steven R, ELLIS, Stephen G, WOLSKI, Kathy, LINCOFF, A. Michael, TOPOL, Eric J

Volltext

abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile von Kereiakes, Dean J., Lincoff, A.Michael, Anderson, Keaven M., Achenbach, Robert, Patel, Kamlesh, Barnathan, Elliot, Califf, Robert M., Topol, Eric J.

Volltext

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT) von Islam, M.Ashequl, Blankenship, James C, Balog, Craig, Iliadis, Elias A, Lincoff, A.Michael, Tcheng, James E, Califf, Robert M, Topol, Eric J

Volltext

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials von Lincoff, A.Michael, LeNarz, LeRoy A, Despotis, George J, Smith, Peter K, Booth, Joan E, Raymond, Russell E, Sapp, Shelly K, Cabot, Catherine F, Tcheng, James E, Califf, Robert M, Effron, Mark B, Topol, Eric J

Volltext

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade von Epistent Investigators, T

Volltext